LinkedIn·Tuesday, 11 August 2026·15d ago
👁️ Most pharma data governance protects data by making it invisible. Privacy legislation and internal governance processes exist for good…
ONTOFORCE
4,907 followers
👁️ Most pharma data governance protects data by making it invisible.
Privacy legislation and internal governance processes exist for good reason. The problem isn't that governance is too strict; it's architectural. When access is enforced system by system, a researcher has to specify exactly what data they need before they can request it, and they can only know that by having already seen the data. It's a deadlock built into how most governance gets implemented, and it's a big part of why a cohort request can take weeks to assemble and submit.
Our latest post looks at what it takes to break that deadlock: aggregation by default, anonymity thresholds, data lineage, and a request path that carries its own audit trail. Enforced once, instead of separately everywhere it's accessed.
Read on: https://lnkd.in/e_v3KNje
♥ 4💬 1
View on LinkedIn Cross-referenced
Related on the wire
Yesterday our marketing, sales, and operations teams stepped away from their desks for an afternoon of team building and friendly…
We're #hiring a new Senior Data Engineer, Public Data Packages in Ghent, Flemish Region. Apply today or share this post with your network.
👏 We're happy to share that Jelle Fauconnier has joined ONTOFORCE as a Junior Software Engineer within the R&D team. Jelle isn't new to…
Most AI deployments in life sciences aren't agentic. They're just faster versions of the same workflow. Lieven Poelman, VP R&D at…
We've introduced governed workspaces into DISQOVER that give each team its own curated view of data, without duplicating infrastructure or…
The life sciences industry keeps talking about "AI-ready data." But have we agreed on a definition for the term? Some mean clean data. Some…